JPRN-UMIN000035115已完成2 期
Verification of the prevention effect of daily high-dose Japanese cedar pollen peptide-containing rice on onset from non-onset of Japanese cedar pollinosis(Study3) - Verification of the prevention effect of daily high-dose Japanese cedar pollen peptide-containing rice on onset from non-onset of Japanese cedar pollinosis
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)those whom Principal Investigator or the sharing researchers have determined inappropriate 2)those who suffer from rice allergy or have a history of rice allergy 3)those who have received immunotherapy for cedar pollen, or have the schedule 4)those who suffer from some serious disease with disease activity, therefore, are judged unsuitable for enrolement by the clinician 5)those who are or planning to become pregnant or in the process of breast-feeding during the clinical reseach 6)those who are participating in other clinical research
研究者
相似试验
已完成
3 期
Intervention study to assess the effect of daily consumption of a lutein-enriched-egg beverage on maintenance of visual function in subjects with early signs of Age-related Macular DegeneratioAMDMacular Disease10047060Age-related Macular DegenerationNL-OMON41009ewtricious R&D20
尚未招募
不适用
The Curative Effect Evaluation and Daily Monitoring of TCM Constitution Diet Control and Physical Training in the Prevention and Treatment of Simple Fatty LiverITMCTR2000003804Shuguang Hospital Affiliated Shanghai University of Traditional Chinese Medicine
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusObesityEUCTR2014-001540-38-GBovo Nordisk A/S957
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusMedDRA version: 18.1Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersObesityEUCTR2014-001540-38-BEovo Nordisk A/S935
进行中（未招募）
1 期
Investigation of safety and efficacy of once-daily semaglutide in obese subjects without diabetes mellitusObesityEUCTR2014-001540-38-DEovo Nordisk A/S935